Contents > FSAHandbook BIPRU 13.3...
Page last published: 18 February 2010

Financial Services Authority
FSA Handbook of Rules and Guidance
Block 2a     Prudential standards
BIPRU          Prudential sourcebook for Banks, Building Societies and Investment Firms
[Made 25 October 2006] [Commencement: 1 January 2007]
BIPRU 13    The calculation of counterparty risk exposure values for financial derivatives, securities financing transactions and long settlement transactions
BIPRU 13.3 Calculation of exposure values for financial derivatives and long settlement transactions: General provisions

Financial derivative instruments

13.3.1 R A firm must determine the exposure value of a financial derivative instrument in accordance with BIPRU 13, with the effects of contracts of novation and other netting agreements taken into account for the purposes of those methods in accordance with BIPRU 13.

[Note: BCD Article 78(2) first sentence]

13.3.2 R Subject to BIPRU 13.3, a firm must determine the exposure value for financial derivative instruments with the CCR mark to market method, the CCR standardised method or the CCR internal model method.

[Note: BCD Annex III Part 2 point 1]

Definition of financial derivative instrument

13.3.3 R Each of the following is a financial derivative instrument:

(1) an interest-rate contract, being:

(a) a single-currency interest rate swap;

(b) a basis-swap;

(d) an interest-rate future;

(e) a purchased interest-rate option; and

(f) other contracts of similar nature;

(2) a foreign currency contract or contract concerning gold, being:

(a) a cross-currency interest-rate swap;

(b) a forward foreign currency contract;

(d) a currency option purchased;

(e) other contracts of a similar nature; and

(f) a contract concerning gold of a nature similar to (2)(a) to (e).

(3) a contract of a nature similar to those in 1(a) to (e) and 2(a) to (d) concerning other reference items or indices, including as a minimum all instruments specified in points 4 to 7, 9 and 10 of Section C of Annex I to the MIFID not otherwise included in (1) or (2).

[Note: BCD Annex IV]

Long settlement transactions

13.3.4 R Long settlement transaction means a transaction where a counterparty undertakes to deliver a security, a commodity, or a foreign currency amount against cash, other financial instruments, or commodities, or vice versa, at a settlement or delivery date that is contractually specified as more than the lower of the market standard for this particular transaction and five business days after the date on which the firm enters into the transaction.

[Note: BCD Annex III Part 1 point 3]

13.3.5 R A firm must calculate the exposure value of a long settlement transaction in accordance with either:

(1) BIPRU 13; or

(2) the master netting agreement internal models approach, if it has a master netting agreement internal models approach waiver which permits it to apply that approach.

[Note: BCD Article 78(2) second sentence, in respect of long settlement transactions]

13.3.6 R A firm may determine exposures arising from long settlement transactions using any of the CCR mark to market method, the CCR standardised method and the CCR internal model method, regardless of the methods chosen for treating financial derivatives instruments and repurchase transactions, securities or commodities lending or borrowing transactions, and margin lending transactions. In calculating capital requirements for long settlement transactions, a firm that uses the IRB approach may apply the risk weights under the standardised approach on a permanent basis and irrespective of the materiality of such positions.

[Note: BCD Annex III Part 2 point 7]

13.3.7 G A firm is not required to calculate the exposure value of a transaction as a long settlement transaction for the purposes of BIPRU 13 if the transaction is a financial derivative instrument or a securities financing transaction and the firm chooses to calculate the capital requirement for the transaction according to the methods applicable to those exposures.

General netting

13.3.8 R Under the CCR mark to market method, the CCR standardised method and the CCR internal model method, a firm must determine the exposure value for a given counterparty as equal to the sum of the exposure values calculated for each netting set with that counterparty.

[Note: BCD Annex III Part 2 point 5]

13.3.9 R A firm may only recognise netting for the purposes of BIPRU 13.4, BIPRU 13.5 and BIPRU 13.6 if the requirements in BIPRU 13.7 are met.

Combined use

13.3.10 R The combined use of the CCR mark to market method, the CCR standardised method and the CCR internal model method is not permitted. The combined use of the CCR mark to market method and the CCR standardised method is permitted where one of the methods is used for the cases set out in BIPRU 13.5.9 to BIPRU 13.5.10R.

[Note: BCD Annex III Part 2 point 1(part)]

13.3.11 G The combined use of different approaches may be used across a group as described in BIPRU 8.7.8R and BIPRU 8.7.9R.

Exposure to a central counterparty

13.3.12 R Notwithstanding BIPRU 13.3.1R and BIPRU 13.3.5R, a firm may determine the exposure value of a credit risk exposure outstanding with a central counterparty in accordance with BIPRU 13.3.13R, provided that the central counterparty's counterparty credit risk exposures with all participants in its arrangements are fully collateralised on a daily basis.

[Note: BCD Article 78(4) in respect of financial derivatives and long settlement transactions]

13.3.13 R A firm may attribute an exposure value of zero for CCR to derivative contracts and long settlement transactions, or to other exposures arising in respect of those contracts or transactions (but excluding an exposure arising from collateral held to mitigate losses in the event of the default of other participants in the central counterparty's arrangements) where they are outstanding with a central counterparty and have not been rejected by the central counterparty.

[Note: BCD Annex III Part 2 point 6 in respect of financial derivatives and long settlement transactions]

Exceptions

13.3.14 R When a firm purchases credit derivative protection against a non-trading book exposure, or against a CCR exposure, it must compute its capital requirement for the hedged asset in accordance with:

(1) BIPRU5.7.16R to BIPRU 5.7.25R and BIPRU 4.10.49(4) to (6) (Unfunded credit protection: Valuation and calculation of risk-weighted exposure amounts and expected loss amounts);

(2) BIPRU 4.4.79R (Double default); or

(3) BIPRU 4.10.40R to BIPRU 4.10.48R (Unfunded credit protection: Minimum requirements for assessing the effect of guarantees and credit derivatives).

[Note: BCD Annex III Part 2 point 3 (part)]

13.3.15 R In the cases in BIPRU 13.3.14R, a firm must set the exposure value for CCR for these credit derivatives to zero.

[Note: BCD Annex III Part 2 point 3 (part)]

13.3.16 R A firm must set the exposure value for CCR from sold credit default swaps in the non-trading book, where they are treated as credit protection provided by the firm and subject to a capital requirement for credit risk for the full notional amount, to zero.

[Note: BCD Annex III Part 2 point 4]